𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations

✍ Scribed by Eva Pros; Juana Fernández-Rodríguez; Belén Canet; Llúcia Benito; Aurora Sánchez; Ana Benavides; Feliciano J. Ramos; María Asunción López-Ariztegui; Gabriel Capellá; Ignacio Blanco; Eduard Serra; Conxi Lázaro


Book ID
102263867
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
427 KB
Volume
30
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A variable combination of features of No
✍ Ulrike Hüffmeier; Martin Zenker; Juliane Hoyer; Raimund Fahsold; Anita Rauch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 1 views

## Abstract Signs of neurofibromatosis type 1 (NF1) and Noonan syndrome (NS), two distinct autosomal dominant disorders, occur together in patients reported as Watson syndrome (WS), neurofibromatosis‐Noonan syndrome (NFNS), partial LEOPARD syndrome, NS with features of NF1, and NF1 with Noonan‐like

Antisense oligonucleotide treatment for
✍ Laura Rodríguez-Pascau; Maria Josep Coll; Lluïsa Vilageliu; Daniel Grinberg 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 1 views

Niemann-Pick type C disease is an autosomal recessive disorder caused by mutations in either the NPC1 or NPC2 gene. While most of the mutations are missense, a few splicing mutations have also been described. We identified and characterized a novel point mutation c.1554-1009G>A located in intron 9 o